Thermo Fisher rises as JPMorgan adds October pick
Alpha Vantage · TradingView · · AI-summarised by FinFlash
Thermo Fisher Scientific shares rose about 1.1% to $662.27 after JPMorgan added the company to its October growth selections. Second-quarter results showed revenue climbing 10% and operating income up 14%, signaling improved profitability. Analysts maintain a Buy/Hold/Sell split of 22/5/1, with an average target of $652.85, slightly below the current price. Sustained organic growth and margin gains remain key for investor confidence.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.